IMA MED-TECH and IMA Life at Combination Products Seminar 2026

IMA MED-TECH, together with IMA Life, will participate in the Combination Products Seminar 2026, taking place on 16-17 September 2026 in Tokyo, Japan.

As the pharmaceutical industry accelerates the development of combination products, manufacturers are facing increasing pressure to industrialize innovative therapies while ensuring compliance, efficiency and product quality. The growing adoption of self-administration therapies, biologics and high-value injectable drugs is driving demand for advanced manufacturing solutions capable of integrating pharmaceutical processing with medical device assembly.

The Combination Products Seminar 2026 will bring together industry professionals to discuss the future of drug delivery systems, with a particular focus on the technologies and processes supporting next-generation therapies. Topics will include evolving regulatory requirements, device usability, manufacturing challenges and quality considerations associated with the integration of pharmaceutical products and medical devices.

Across the two-day program, participants will explore emerging trends in autoinjectors, pen injectors, wearable technologies and other patient-centric delivery platforms designed to improve treatment accessibility and enhance the patient experience. The event will also examine the growing role of automation and digitalization in supporting the efficient production of increasingly complex combination products.

For manufacturers of injectable therapies, seamless integration between aseptic processing and device assembly is becoming a strategic requirement. In this context, IMA MED-TECH and IMA Life will share their expertise in developing connected production environments that combine fill-finish technologies with downstream automation, enabling higher productivity, enhanced process control and faster time-to-market.

Presentation Session

17 September 2026 | 12:15 - 12:55 Speaker: Izumisawa Miki, Country Manager, Sales at IMA Life Japan Integrated All-in-One Platforms for High-Speed Production of Subcutaneous Injectable Products

This presentation will focus on integrated manufacturing platforms designed for the high-speed production of subcutaneous injectable products, combining aseptic filling, device assembly and packaging operations within a connected production environment.

The session will highlight how the integration of fill-finish technologies with automated solutions for autoinjectors, pen injectors and safety devices can support efficiency, product quality and compliance with evolving EU GMP Annex 1 requirements, while enabling faster industrialization of innovative combination products.

Meet the IMA MED-TECH and IMA Life teams in Tokyo to discover how integrated automation can support the future of injectable drug delivery manufacturing.

We look forward to meeting you in Tokyo!

X-PEN Autoinjector 40 PPM